---
reference_id: "PMID:22687587"
title: Echocardiography to individualize treatment for hypertrophic cardiomyopathy.
authors:
- Sherrid MV
- Arabadjian M
journal: Prog Cardiovasc Dis
year: '2012'
doi: 10.1016/j.pcad.2012.04.007
content_type: abstract_only
---

# Echocardiography to individualize treatment for hypertrophic cardiomyopathy.
**Authors:** Sherrid MV, Arabadjian M
**Journal:** Prog Cardiovasc Dis (2012)
**DOI:** [10.1016/j.pcad.2012.04.007](https://doi.org/10.1016/j.pcad.2012.04.007)

## Content

1. Prog Cardiovasc Dis. 2012 May-Jun;54(6):461-76. doi:
10.1016/j.pcad.2012.04.007.

Echocardiography to individualize treatment for hypertrophic cardiomyopathy.

Sherrid MV(1), Arabadjian M.

Author information:
(1)Division of Cardiology, St Luke's-Roosevelt Hospital Center, Columbia 
University, College of Physicians and Surgeons, 1000 10th Ave, New York City, NY 
10019, USA. msherrid@chpnet.org

Treatments for hypertrophic cardiomyopathy are largely selected based on patient 
symptoms and echocardiographic findings. Moreover, all the advanced treatments 
for heart failure symptoms depend on such imaging for planning and monitoring 
response to therapy. Risk of sudden death correlates with maximum left 
ventricular (LV) wall thickness. Massive LV thickening of 30 mm or more is an 
indication for primary prevention of sudden death with an implanted 
defibrillator. In this review, we will underscore potential pitfalls in 
echocardiographic diagnosis. Also we will review, a newly appreciated 
pathophysiologic mechanism in obstruction dynamic systolic dysfunction due to 
gradient.

Copyright Â© 2012. Published by Elsevier Inc.

DOI: 10.1016/j.pcad.2012.04.007
PMID: 22687587 [Indexed for MEDLINE]